every analyst has plx at $8/sh tops,,, IF it gets fda approval....
it previously got crl letter.
no guarantee fda approval....... pps now 6.75........ i dont like risk/reward.........
affy has fda approval and a huge patient population and much larger upside........
i dont agree w/your post "advice"..... gl2u nonetheless. im staying long and strong affy.